We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BBLGW market cap is 80.51M. The company's latest EPS is USD -2.8555 and P/E is -0.64.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.22M | -1.29M | -3.15M | -3.04M | -2.08M |
| Net Income | -1.22M | 893k | -3.71M | -1.77M | -1.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.45M | -825k | -1.1M | -3.67M | -9.43M |
| Net Income | -3.43M | -1.83M | -1.61M | -1.49M | -8.95M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.2M | 8.5M | 6.78M | 7.62M | 4.98M |
| Total Liabilities | 799k | 2.55M | 4.01M | 1.93M | 1.18M |
| Total Equity | 4.4M | 5.95M | 2.77M | 5.69M | 3.79M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31k | 0 | 6.68M | 8.5M | 3.74M |
| Total Liabilities | 11.9M | 13.69M | 100k | 2.55M | 832k |
| Total Equity | -11.87M | -13.69M | 6.58M | 5.95M | 2.91M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.62M | -3.57M | -1.35M | -4.98M | -7.54M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | 4.43M | N/A | 4.45M | 4.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.25M | -427k | -1.23M | -3.57M | -9.56M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.32M | 403k | 7.9M | 4.43M | 5.04M |
| Market Cap | 80.51M |
| Price to Earnings Ratio | -0.64 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.89 |
| Price to Book Ratio | 1.97 |
| Dividend Yield | - |
| Shares Outstanding | 3.13M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 11.9 (39.8%) |
| Company Name | Bone Biologics Corporation |
| Address |
1013 centre road wilmington, delaware 19805 |
| Website | https://www.bonebiologics.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
